Friday, January 19, 2018 5:15:11 PM
Fully Diluted O/S around 53M shares!
NEMUS Bioscience, Inc. (OTC:NMUS) is pleased to announce that it has received the remaining $400,000 under the previously announced Bridge Loan with Emerald Health Sciences Inc. (“Emerald”)
https://www.dailymarijuanaobserver.com/single-post/2018/01/19/NMUS-Nemus-Receives-400000-Under-Bridge-Loan-and-Closes-Private-Placement
We greatly value the intellectual capital and discovery capacity of the University of Mississippi, with which Nemus has an exclusive agreement for novel cannabinoid technologies. We will work to support the business and developmental vision of our CEO, Dr. Murphy, across a spectrum of medical indications of unmet need. The Emerald Board believes that Nemus presents a significant value proposition for investors and we look forward to advancing its pipeline into clinical development.”
http://beta.latimes.com/nation/la-na-pot-monopoly-20140529-story.html
Emerald holds a majority of Nemus’ common shares on a deemed fully converted basis. Nemus’ current directors have resigned, except for Dr. Brian Murphy, who has been joined by Punit Dhillon and Jim Heppell as directors of the company. Mr. Dhillon and Mr. Heppell are also directors of Emerald.
http://emeraldhealth.ca/board-management/jim-heppell/#
http://emeraldhealth.ca/board-management/punit-dhillon/
http://emeraldhealth.ca/board-management/avtar-dhillon/
“We welcome Nemus into Emerald’s family of life science companies,” commented Dr. Avtar Dhillon, CEO and Chairman of Emerald’s Board of Directors.
Lift Cannabis Expo | Interview with Chris Wagner
Chris Wagner, CEO of Emerland Health Therapeutics, explains Emerald's work with scientists and researchers around the world plus the importance of standardization, dosing and delivery - and more!
Recent SKYE News
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/10/2024 08:19:14 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/10/2024 08:17:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:02:13 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM